insights_auto
Why is SNW up 2.96%?
Dive Deeperchevron_right
SNW:FRA
Sanofi SA
€73.50
arrow_upward
+2.96%(+2.11) 1D
Oct 20, 5:06:56 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNW...
Open
€71.14
High
€73.50
Low
€71.14
Mkt. cap
88.87B
Avg. vol.
2.07K
Volume
870.00
P/E ratio
22.54
52-wk high
€90.46
52-wk low
€69.89
EPS
€3.26
Shares outstanding
1.25B
No. of employees
75K
Open
€71.14
High
€73.50
Low
€71.14
Mkt. cap
88.87B
Avg. vol.
2.07K
Volume
870.00
P/E ratio
22.54
52-wk high
€90.46
52-wk low
€69.89
EPS
€3.26
Shares outstanding
1.25B
No. of employees
75K
News stories
From web sources and news partners
ad-hoc-news.de
·
3 hours ago
Sanofi stock: Leerink Partners sets EUR 94.00 target for Sanofi stock
Yahoo Finance
·
3 hours ago
ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics
Stock Traders Daily
·
4 hours ago
(SNY) Movement Within Algorithmic Entry Frameworks
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74.8K
Founded1973
HeadquartersParis, Île-de-France, France
SectorPharmaceutical industry
Websitesanofi.com